Biotech company develops targeted therapies using proprietary platform to enhance protein function through deubiquitinase enzyme modulation.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Entactbio is a biotechnology company focused on creating innovative therapies using its proprietary Encompass™ platform. The company designs drug candidates that target deubiquitinase enzymes to enhance the function of specific proteins, with the goal of treating a wide array of diseases. By utilizing the body’s natural mechanisms, Entact Bio aims to expand the types of conditions that can be effectively treated.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Entactbio Management Team
Entactbio Valuations & Financials
View real-time NPM data on Entactbio stock including daily Entactbio stock price estimates, valuation history, and historical share price information. Access Entactbio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Entactbio pricing across six independent market signals. Looking for private company due diligence data sources on Entactbio? Get in touch to learn more.
Similar Companies
like Entactbio
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Firefly Health
Healthcare & Life Sciences
Virtual healthcare provider delivers comprehensive primary care and mental health services through digital platform and local partnerships.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Eikonoklastes Therapeutics
Healthcare & Life Sciences
Develops that enhance neuromuscular function by overexpressing Caveolin-1 in neurons, aiming to modify disease progression in neurodegenerative conditions.
Ro
Healthcare & Life Sciences
Healthcare technology for a patient-centric healthcare system.
Somatus
Healthcare & Life Sciences
Integrated care for patients with or at risk of developing kidney disease.
FAQ
We have answers
Entactbio stock does not trade on public stock exchanges. Entactbio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Entactbio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Entactbio Stock does not trade on public stock exchanges. In order to sell Entactbio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Entactbio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Entactbio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Entactbio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Entactbio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Entactbio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Entactbio is a private company and has not had an IPO. There is currently no Entactbio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Entactbio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
